Altimmune
ALT
ALT
30 hedge funds and large institutions have $2.18M invested in Altimmune in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
28% less call options, than puts
Call options by funds: $41K | Put options by funds: $57K
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
Holders
30
Holding in Top 10
–
Calls
$41K
Puts
$57K
Top Buyers
| 1 | +$106K | |
| 2 | +$104K | |
| 3 | +$85K | |
| 4 |
Bank of New York Mellon
New York
|
+$84K |
| 5 |
VF
Virtu Financial
New York
|
+$59K |
Top Sellers
| 1 | -$235K | |
| 2 | -$54.7K | |
| 3 | -$48.9K | |
| 4 |
D.E. Shaw & Co
New York
|
-$29K |
| 5 |
Squarepoint
New York
|
-$20.1K |